Want to join the conversation?
$BIIB and $IONS said $BIIB closed rolling submission of a New Drug Application (NDA) to the FDA for approval of nusinersen, an investigational treatment for spinal muscular atrophy (SMA). $BIIB has also applied for Priority Review which, if granted, would shorten the review period of nusinersen after the Agency's acceptance of the NDA.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!